Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers

Biological Psychiatry

Volumn 64, Issue 3, 2008, Pages 241-247

  Reetz, Kathrin ^a,b   Lencer, Rebekka ^a   Steinlechner, Susanne ^a   Gaser, Christian ^d   Hagenah, Johann ^a   Büchel, Christian ^b,c   Petersen, Dirk ^a   Kock, Norman ^a   Djarmati, Ana ^a   Siebner, Hartwig R ^b,e   Klein, Christine ^a   Binkofski, Ferdinand ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NeuroImage Nord   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

Hippocampus; Parkinson's disease; PINK1; psychiatric disorders; voxel based morphometry

Indexed keywords

CELL PROTEIN; PTEN INDUCED PUTATIVE KINASE 1;

ADJUSTMENT DISORDER; ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; MORPHOMETRICS; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBICULUM;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; NEUROLOGIC EXAMINATION; PROTEIN KINASES; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS;

EID: 46449110289     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.12.010     Document Type: Article

References (49)

1. Schrag A. Psychiatric aspects of Parkinson's disease-an update. J Neurol 251 (2004) 795-804
2. Ramirez A., Heimbach A., Grundeman J., Stiller B., Hampshire D., Cid L.P., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38 (2006) 1184-1190
3. Klein C., and Schlossmacher M.G. The genetics of Parkinson disease: Implications for neurological care. Nat Clin Pract Neurol 2 (2006) 136-146
4. Bonifati V., Rohe C.F., Breedveld G.J., Fabrizio E., De Mari M., Tassorelli C., et al. Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes. Neurology 65 (2005) 87-95
5. Hedrich K., Hagenah J., Djarmati A., Hiller A., Lohnau T., Lasek K., et al. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: Role of a single hit?. Arch Neurol 63 (2006) 833-838
6. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study. Mov Disord 15 (2000) 669-677
7. Gonera E.G., van't Hof M., Berger H.J., van Weel C., and Horstink M.W. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12 (1997) 871-876
8. Hubble J.P., Cao T., Hassanein R.E., Neuberger J.S., and Koller W.C. Risk factors for Parkinson's disease. Neurology 43 (1993) 1693-1697
9. Dooneief G., Mirabello E., Bell K., Marder K., Stern Y., and Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 49 (1992) 305-307
10. Oertel W.H., Hoglinger G.U., Caraceni T., Girotti F., Eichhorn T., Spottke A.E., et al. Depression in Parkinson's disease. An update. Adv Neurol 86 (2001) 373-383
11. Aarsland D., Larsen J.P., Lim N.G., Janvin C., Karlsen K., Tandberg E., et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 67 (1999) 492-496
12. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol 56 (2004) 424-427
13. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., et al. Parkin disease: A phenotypic study of a large case series. Brain 126 (2003) 1279-1292
14. Rohe C.F., Montagna P., Breedveld G., Cortelli P., Oostra B.A., and Bonifati V. Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol 56 (2004) 427-431
15. Steinlechner S., Stahlberg J., Völkel B., Djarmati A., Hagenah J., Hiller A., et al. Co-occurence of affective and schizophrenia spectrum disorders with PINK1 mutations. JNNP 78 (2007) 532-535
16. Klein C., Pramstaller P.P., Kis B., Page C.C., Kann M., Leung J., et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype. Ann Neurol 48 (2000) 65-71
17. Hedrich K., Kann M., Lanthaler A.J., Dalski A., Eskelson C., Landt O., et al. The importance of gene dosage studies: Mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10 (2001) 1649-1656
18. Kann M., Jacobs H., Mohrmann K., Schumacher K., Hedrich K., Garrels J., et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol 51 (2002) 621-625
19. Binkofski F., Reetz K., Gaser C., Hilker R., Hagenah J., Hedrich K., et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 69 (2007) 842-850
20. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001) 21-36
21. Job D.E., Whalley H.C., McConnell S., Glabus M., Johnstone E.C., and Lawrie S.M. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res 64 (2003) 1-13
22. Chua S.E., Cheung C., Cheung V., Tsang J.T., Chen E.Y., Wong J.C., et al. Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr Res 89 (2007) 12-21
23. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (2000) 16-25
24. Frodl T., Schaub A., Banac S., Charypar M., Jager M., Kummler P., et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 31 (2006) 316-325
25. Wu J., Buchsbaum M.S., Gillin J.C., Tang C., Cadwell S., Wiegand M., et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156 (1999) 1149-1158
26. Benedetti F., Bernasconi A., and Pontiggia A. Depression and neurological disorders. Curr Opin Psychiatry 19 (2006) 14-18
27. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003) 1516-1518
28. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc 57 (2000) 289-300
29. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 (2003) 1233-1239
30. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris N., Lee H., et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 56 (1999) 537-547
31. Gur R.E., Turetsky B.I., Bilker W.B., and Gur R.C. Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry 56 (1999) 905-911
32. Heckers S., and Konradi C. Hippocampal neurons in schizophrenia. J Neural Transm 109 (2002) 891-905
33. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 61 (2004) 974-984
34. Smith M.E. Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: A meta-analysis of structural MRI studies. Hippocampus 15 (2005) 798-807
35. Kantarci K., and Jack Jr. C.R. Neuroimaging in Alzheimer disease: An evidence-based review. Neuroimaging Clin N Am 13 (2003) 197-209
36. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 157 (2000) 115-118
37. Dhikav V., and Anand K.S. Is hippocampal atrophy a future drug target?. Med Hypotheses 68 (2007) 1300-1306
38. Maclean P.D. The limbic system ("visceral brain") and emotional behavior. AMA Arch Neurol Psychiatry 73 (1955) 130-134
39. Hadland K.A., Rushworth M.F., Gaffan D., and Passingham R.E. The effect of cingulate lesions on social behaviour and emotion. Neuropsychologia 41 (2003) 919-931
40. Voigt B.A., and Laureys S. Posterior cingulate, precuneal and retrosplenial cortices: cytology and components of the neural network correlates of consciousness. Prog Brain Res 150 (2005) 205-217
41. Kennerley S.W., Walton M.E., Behrens T.E., Buckley M.J., and Rushworth M.F. Optimal decision making and the anterior cingulate cortex. Nat Neurosci 9 (2006) 940-947
42. Volz K.G., Schubotz R.I., and von Cramon D.Y. Decision-making and the frontal lobes. Curr Opin Neurol 19 (2006) 401-406
43. Volz K.G., Schubotz R.I., and von Cramon D.Y. Variants of uncertainty in decision-making and their neural correlates. Brain Res Bull 67 (2005) 403-412
44. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr Res 49 (2001) 1-52
45. Lawrie S.M., and Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172 (1998) 110-120
46. Quirk G.J., Garcia R., and Gonzalez-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 60 (2006) 337-343
47. Sotres-Bayon F., Bush D.E., and LeDoux J.E. Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction. Learn Mem 11 (2004) 525-535
48. Shackman A.J., Sarinopoulos I., Maxwell J.S., Pizzagalli D.A., Lavric A., and Davidson R.J. Anxiety selectively disrupts visuospatial working memory. Emotion 6 (2006) 40-61
49. Taymans J.M., Van den Haute C., and Baekelandt V. Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98 (2006) 951-961